Page 228 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 228

14









                              The Microbiota in Immunity and Inflammation



                                                                                                  Craig L. Maynard







           Humans and other species of mammals are hosts to an array of   the mammalian immune system and the microscopic inhabitants
           microbial communities collectively referred to as the microbiota.   of the various barrier surfaces.
           The microbiota comprises prokaryotes (bacteria and archaea),
           viruses (bacteriophages as well as eukaryotic viruses), and eukarya   Viruses
           or the meiofauna (mainly fungi and protozoa). As revealed by   The viruses that inhabit mammalian hosts can be subdivided
           the Human Microbiome Project, specialized subcommunities   into bacteriophages, which infect prokaryotic cells; eukaryotic
           colonize barrier surfaces of the digestive, respiratory, and uro-  viruses, which infect host and other eukaryotic cells; and virus-
           genital tracts, and skin. Our immune system is believed to have   derived genetic elements, which can incorporate into host
           evolved to ensure peaceful coexistence with these microorganisms   chromosomes and result in the generation of infectious virus
           that aid in immune homeostasis, pathogen resistance, and diges-  at a later date. It has been difficult to quantify the exact size of
           tion in exchange for a nutrient-rich habitat. There is a perpetual   the virome. In the case of bacteriophages, it is generally accepted
           cross-talk between the microbiota and the immune system   that they can exist in 10-fold greater numbers than prokaryotes.
           throughout an individual’s life. Specific modulation of this   Bacteriophages can have profound effects on the structure and
           microbiota, particularly in infancy, has important long-term   functions of intestinal prokaryotic communities via viral gene
           health  consequences.  Addition  of  specific  symbionts  to  the   transfer of virulence factors and antibiotic-resistant genes between
           microbiota can provide tangible health benefits. Reconstitution   prokaryotic organisms or through predator–prey relationships.
           of a dysbiotic microbiota continues to be utilized or explored   Indeed, the infectivity of some enteric viruses requires the
                                                                           2
           as therapy for inflammatory diseases.                  microbiota.  Eukaryotic viruses include a vast array of viruses
                                                                  that permanently infect the host and can exist for decades in
           OVERVIEW OF OUR NONMAMMALIAN “SELF”                    asymptomatic individuals. These viruses can persist locally or
                                                                  systemically. They can directly impact tissue-specific immunity,
           Exposure to the microbiota and its products occurs via a gradual,   including in the GI tract.
           ordered process. It  begins  in  utero  and  accelerates  during
           and after birth. The overall composition of an individual’s   Fungi
           microbiota is impacted by such phenomena as the method of   Collectively referred to as the mycobiota, fungal communities
           birth delivery, diet, treatment with antibiotics, and environmental   represent a considerably smaller proportion of the total microbes
           exposures. All of these modifying factors can have lasting effects   in the human body. Commensal fungi can be detected in the
           on immune health.                                      mouth, lungs, intestines, vagina, and skin (Fig. 14.2). Advances
                                                                  in our knowledge and understanding of the size and functions
           Prokaryotes                                            of the mycobiota have been hampered by relatively limited
           The bacterial component of our microbiota is, by far, the most   genomics and bioinformatics capabilities when compared with
           widely studied. This has been made possible, in part, by a fairly   the study of bacteria or viruses. However, studies utilizing broad-
           recent explosion of genomic and bioinformatics capabilities that   spectrum antifungal agents have begun to highlight the possible
           has enabled taxonomic identification, and even enumeration,   roles played by fungi in protecting against disease processes,
           of the members of microbial communities without the need for   such as inflammatory bowel disease (IBD) (Chapter 75).
           bacterial culture. Two phyla—Bacteroidetes and Firmicutes—  The microbes that inhabit the human body are often acceptably
           account for almost 90% of intestinal bacteria. The remainder   referred to as the commensal microbiota, which in the strictest
           comprises organisms belonging to the phyla Cyanobacteria,   sense refers to organisms that derive benefit from their host
           Proteobacteria, Actinobacteria, Fusobacteria, and Verrucomicro-  without negatively or positively affecting the host. Although this
              1
           bia.  The bacteria that colonize humans belong mainly to three   is true of some members of the microbiota, our relationship
           major phyla: Bacteroidete, Firmicutes, and Proteobacteria. It is   with other microbes is one of mutualism, whereby each organism
           estimated that the average human being plays host to approxi-  performs unique and necessary functions that benefit the other.
           mately 100 trillion bacteria. Most of these cells inhabit the lumen   For example, certain bacteria find a home in the anaerobic
           of the gastrointestinal (GI) tract. The density of bacteria increases   environment of the cecum and proximal colon, where they receive
                     3
                  2
                                                       12
           from ≈10 –10  bacterial cells per mL in the stomach to 10  cells/  a rich source of nutrients in the form of insoluble carbohydrates,
           mL in the distal large intestine (Fig. 14.1). The sheer number   which our own digestive enzymes are unable to process. By the
           of bacteria sets the stage for a very complex relationship between   process of anaerobic fermentation, these carbohydrates are broken
                                                                                                                207
   223   224   225   226   227   228   229   230   231   232   233